Trends and Disparities Around Cardiovascular Mortality in Sarcoidosis: Does Big Data Have the Answers?
作者信息
Ahmed Raheel, Sharma Rakesh, Chahal C Anwar A
机构信息
Heart Division Royal Brompton Hospital, Guy's and St Thomas' NHS Trust London United Kingdom.
National Heart and Lung Institute, Imperial College London London United Kingdom.
出版信息
J Am Heart Assoc. 2024 Apr 2;13(7):e034073. doi: 10.1161/JAHA.124.034073. Epub 2024 Mar 27.
Abstract
摘要
相似文献
1
Trends and Disparities Around Cardiovascular Mortality in Sarcoidosis: Does Big Data Have the Answers?结节病中心血管疾病死亡率的趋势与差异：大数据能给出答案吗？
J Am Heart Assoc. 2024 Apr 2;13(7):e034073. doi: 10.1161/JAHA.124.034073. Epub 2024 Mar 27.
2
Hospitalization Rates, Prevalence of Cardiovascular Manifestations, and Outcomes Associated With Sarcoidosis in the United States.美国结节病的住院率、心血管表现的患病率及相关结局。
J Am Heart Assoc. 2018 Jan 22;7(2):e007844. doi: 10.1161/JAHA.117.007844.
3
Trends and Disparities in Cardiovascular Death in Sarcoidosis: A Population-Based Retrospective Study in the United States From 1999 to 2020.美国 1999 年至 2020 年基于人群的回顾性研究：结节病中心血管死亡趋势和差异。
J Am Heart Assoc. 2024 Apr 2;13(7):e031484. doi: 10.1161/JAHA.123.031484. Epub 2024 Mar 27.
4
[Cardiovascular diseases in sarcoidosis].[结节病中的心血管疾病]
Probl Tuberk. 1991(2):71-4.
5
Disparities in Sarcoidosis Mortality by Region, Urbanization, and Race in the United States: A Multiple Cause of Death Analysis.美国不同地区、城市化程度和种族间的结节病死亡率差异：多病因死亡率分析。
Am J Med. 2019 Sep;132(9):1062-1068.e3. doi: 10.1016/j.amjmed.2019.03.048. Epub 2019 Apr 30.
6
Trends in Hospitalizations for Cardiac Sarcoidosis in the United States, 2005-2011.美国 2005-2011 年心脏结节病住院治疗趋势。
Circ J. 2017 Oct 25;81(11):1739-1741. doi: 10.1253/circj.CJ-17-0701. Epub 2017 Sep 13.
7
Sarcoidosis deaths in the United States: 1999-2016.美国的结节病死亡人数：1999-2016 年。
Respir Med. 2019 Mar;149:30-35. doi: 10.1016/j.rmed.2018.11.010. Epub 2018 Nov 16.
8
Sarcoidosis mortality in the United States.美国结节病的死亡率。
Am J Med. 1997 Jan;102(1):131-2.
9
Disease Burden and Variability in Sarcoidosis.结节病的疾病负担和变异性。
Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S421-S428. doi: 10.1513/AnnalsATS.201707-564OT.
10
Socioeconomic determinants and disparities in sarcoidosis.社会经济决定因素与结节病的差异。
Curr Opin Pulm Med. 2020 Sep;26(5):568-573. doi: 10.1097/MCP.0000000000000704.
引用本文的文献
1
Diagnostic Value of Comprehensive Echocardiographic Assessment Including Speckle-Tracking in Patients with Sarcoidosis Versus Healthy Controls: A Systematic Review and Meta-Analysis.综合超声心动图评估（包括斑点追踪）对结节病患者与健康对照者的诊断价值：一项系统评价和荟萃分析
Diagnostics (Basel). 2025 Mar 12;15(6):708. doi: 10.3390/diagnostics15060708.
2
Characteristics and outcomes of hospitalized patients with Isolated and systemic cardiac sarcoidosis: Analysis of the Nationwide readmissions database 2016-2021.孤立性和系统性心脏结节病住院患者的特征与结局：对2016 - 2021年全国再入院数据库的分析
Int J Cardiol Heart Vasc. 2025 Feb 24;57:101636. doi: 10.1016/j.ijcha.2025.101636. eCollection 2025 Apr.
3
Detection of Myocardial Deformation Patterns and Prognostic Value of Routine Echocardiographic Parameters in Patients with Cardiac Sarcoidosis Versus Extracardiac Sarcoidosis: Systematic Review and Meta-Analysis.心脏结节病与心脏外结节病患者心肌变形模式的检测及常规超声心动图参数的预后价值：系统评价与荟萃分析
Diagnostics (Basel). 2025 Feb 20;15(5):518. doi: 10.3390/diagnostics15050518.
4
Nationwide Cross-Sectional Analysis of Mortality Trends in Patients with Sarcoidosis and Non-Ischemic Cardiovascular Disease-The Impact of Gender, Ethnicity, Geographical Location, and COVID-19 Pandemic.结节病和非缺血性心血管疾病患者死亡率趋势的全国性横断面分析——性别、种族、地理位置及新冠疫情的影响
J Clin Med. 2024 Dec 8;13(23):7463. doi: 10.3390/jcm13237463.
5
Outcomes of cardiac resynchronization therapy (CRT) in cardiac sarcoidosis patients with a range of ejection fractions.不同射血分数的心脏结节病患者接受心脏再同步治疗（CRT）的结果。
ESC Heart Fail. 2025 Feb;12(1):592-602. doi: 10.1002/ehf2.15113. Epub 2024 Oct 17.
6
Clinical outcomes following hospitalization for COVID-19 in patients with cardiac sarcoidosis in the United States: a propensity-matched analysis from national inpatient sample database from April 2020 to December 2021.美国心脏结节病患者 COVID-19 住院后的临床结局：一项基于 2020 年 4 月至 2021 年 12 月国家住院样本数据库的倾向匹配分析
Ann Med Surg (Lond). 2024 Aug 22;86(10):5696-5703. doi: 10.1097/MS9.0000000000002474. eCollection 2024 Oct.
7
The role of infliximab in treating refractory cardiac sarcoidosis. Case series and systematic review of literature.英夫利昔单抗在治疗难治性心脏结节病中的作用。病例系列及文献系统综述。
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024013. doi: 10.36141/svdld.v41i2.14484.
本文引用的文献
1
Trends and Disparities in Cardiovascular Death in Sarcoidosis: A Population-Based Retrospective Study in the United States From 1999 to 2020.美国 1999 年至 2020 年基于人群的回顾性研究：结节病中心血管死亡趋势和差异。
J Am Heart Assoc. 2024 Apr 2;13(7):e031484. doi: 10.1161/JAHA.123.031484. Epub 2024 Mar 27.
2
Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.当代心肌结节病患者预后的预测因素：脑利钠肽、左心室功能和心肌炎症的作用。
Eur J Heart Fail. 2023 Dec;25(12):2287-2298. doi: 10.1002/ejhf.3057. Epub 2023 Nov 7.
3
Impact of comorbid heart failure among hospitalized patients with sarcoidosis: A United States population-based cohort study.结节病住院患者合并心力衰竭的影响：一项基于美国人群的队列研究。
Int J Cardiol Heart Vasc. 2023 Sep 29;49:101275. doi: 10.1016/j.ijcha.2023.101275. eCollection 2023 Dec.
4
Prevalence of Pathogenic Variants in Dilated Cardiomyopathy-Associated Genes in Patients Evaluated for Cardiac Sarcoidosis.因心脏结节病接受评估的患者中扩张型心肌病相关基因致病性变异的患病率
Circ Genom Precis Med. 2023 Aug;16(4):409-411. doi: 10.1161/CIRCGEN.122.003850. Epub 2023 May 17.
5
Machine learning predicting mortality in sarcoidosis patients admitted for acute heart failure.机器学习预测因急性心力衰竭入院的结节病患者的死亡率。
Cardiovasc Digit Health J. 2022 Aug 28;3(6):297-304. doi: 10.1016/j.cvdhj.2022.08.001. eCollection 2022 Dec.
6
Outcomes of catheter ablation for ventricular tachycardia in patients with sarcoidosis: Insights from the National Inpatient Sample database (2002-2018).特发性心肌病患者室性心动过速导管消融的结果：来自国家住院患者样本数据库（2002-2018 年）的见解。
J Cardiovasc Electrophysiol. 2022 Dec;33(12):2585-2598. doi: 10.1111/jce.15708. Epub 2022 Nov 24.
7
Risk of Sudden Death in a General Unbiased Epidemiological Cohort of Sarcoidosis.特发性肺含铁血黄素沉着症患者全人群的死亡风险。
J Am Heart Assoc. 2022 Aug 16;11(16):e025479. doi: 10.1161/JAHA.122.025479. Epub 2022 Aug 5.
8
Inpatient characteristics, complications, and outcomes of patients with cardiac sarcoidosis: A study from the National Inpatient Sample.住院患者的特点、并发症和心脏结节病患者的预后：一项来自全国住院患者样本的研究。
Indian Heart J. 2022 Mar-Apr;74(2):148-150. doi: 10.1016/j.ihj.2021.12.012. Epub 2022 Jan 31.
9
Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy.植人性心脏转复除颤器植入术后肉状病心肌病患者的死亡率风险及预测因素。
Am Heart J. 2022 Apr;246:21-31. doi: 10.1016/j.ahj.2021.12.011. Epub 2021 Dec 27.
10
Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review.致心律失常性右室心肌病的炎症和免疫反应：最新综述。
Circulation. 2021 Nov 16;144(20):1646-1655. doi: 10.1161/CIRCULATIONAHA.121.055890. Epub 2021 Nov 15.
Zotero 插件